Biotech companies criticise CRISPR mutation study – BioNews
|
Biotech companies criticise CRISPR mutation study
BioNews Two major biotech companies have criticised a recent study that claimed CRISPR may cause hundreds of unwanted mutations. Scientists from the CRISPR-based firms Intellia Therapeutics and Editas Medicine have written open letters to the journal Nature … |
